| 1 |
33918237 | Columbianadin Dampens In Vitro Inflammatory Actions and Inhibits Liver Injury via Inhibition of NF-κB/MAPKs: Impacts on ∙OH Radicals and HO-1 Expression. | 2021 Apr 2 |
1 |
| 2 |
34703220 | GSK-3β Inhibitors Attenuate the PM2.5-Induced Inflammatory Response in Bronchial Epithelial Cells. | 2021 |
1 |
| 3 |
32230861 | Anti-Inflammatory and Anti-Migratory Activities of Isoquinoline-1-Carboxamide Derivatives in LPS-Treated BV2 Microglial Cells via Inhibition of MAPKs/NF-κB Pathway. | 2020 Mar 27 |
2 |
| 4 |
28498464 | Proinflammatory effects of S100A8/A9 via TLR4 and RAGE signaling pathways in BV-2 microglial cells. | 2017 Jul |
1 |
| 5 |
27121155 | Lentinan mitigates therarubicin-induced myelosuppression by activating bone marrow-derived macrophages in an MAPK/NF-κB-dependent manner. | 2016 Jul |
1 |
| 6 |
24114663 | Isoorientin attenuates lipopolysaccharide-induced pro-inflammatory responses through down-regulation of ROS-related MAPK/NF-κB signaling pathway in BV-2 microglia. | 2014 Jan |
2 |
| 7 |
25084093 | Ginsenoside Rb3 protects cardiomyocytes against ischemia-reperfusion injury via the inhibition of JNK-mediated NF-κB pathway: a mouse cardiomyocyte model. | 2014 |
1 |
| 8 |
24188583 | Attenuation of berberine on lipopolysaccharide-induced inflammatory and apoptosis responses in β-cells via TLR4-independent JNK/NF-κB pathway. | 2013 Nov 5 |
1 |
| 9 |
20026063 | Mechanism of macrophage activation induced by beta-glucan produced from Paenibacillus polymyxa JB115. | 2010 Jan 15 |
1 |
| 10 |
20167866 | Cooperation of TLR2 with MyD88, PI3K, and Rac1 in lipoteichoic acid-induced cPLA2/COX-2-dependent airway inflammatory responses. | 2010 Apr |
1 |
| 11 |
19508391 | Tripterine prevents endothelial barrier dysfunction by inhibiting endogenous peroxynitrite formation. | 2009 Jul |
1 |
| 12 |
18049903 | Acetylcholine inhibits long-term hypoxia-induced apoptosis by suppressing the oxidative stress-mediated MAPKs activation as well as regulation of Bcl-2, c-IAPs, and caspase-3 in mouse embryonic stem cells. | 2008 Feb |
2 |